18008891064
info@ikrispharmanetwork.com
Register Now: IKRIS Breast Cancer Awareness Run 2022
About
Who We Are
How can we help
Resellers
RLD/Innovator Sourcing
Patients and Healthcare Professionals
Products
Commercial Products
Own Label
Immunokris
Polymyxin B
Partner Product
BioMarin Products
RECORDATI products
PTC Products
Media Room
Updates
Contact Us
Nothing Found
Sorry, but nothing matched your search terms. Please try again with some different keywords.
Search for:
×
Search for:
Featured Products
HIV
Abacavir-Lamivudine
Allergic States
,
Dermatologic
,
Endocrine conditions
,
Gastrointestinal Diseases
,
Neoplastic conditions
Prednisolone
Multiple myeloma
Thalidomide
Type-2 diabetes mellitus
Dulaglutide
HIV
Furmecil
Gram-negative bacteria
Amikacin
Trending Articles
Breast cancer
FDA Issues Safety Alert Regarding Reports of SCC in Scar Tissue Around Surrounding Implants
September 15, 2022
2
mins read
Multiple Myeloma
Cipla Gets the Final Approval for Generic Version of Revlimid by US FDA
September 12, 2022
< 1
min read
Acid Sphingomyelinase Deficiency
FDA Approves Xenpozyme: The First Disease-specific Medication for Acid Sphingomyelinase Deficiency (ASMD)
September 8, 2022
2
mins read
Ebola virus
WHO Recommends Two New Lifesaving Medicines to Treat Ebola Virus Disease
August 31, 2022
2
mins read
